17alpha-ethynylestradiol increases expression ISO RGD:1309247 6480464 Ethinyl Estradiol results in increased expression of TJP3 mRNA CTD PMID:17557909 17alpha-ethynylestradiol decreases expression ISO RGD:1309247 6480464 Ethinyl Estradiol results in decreased expression of TJP3 mRNA CTD PMID:29097150 17beta-estradiol multiple interactions ISO RGD:1319483 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of TJP3 mRNA CTD PMID:30165855 2,2',5,5'-tetrachlorobiphenyl decreases expression ISO RGD:1309247 6480464 2 more ... CTD PMID:23829299 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TJP3 mRNA CTD PMID:28922406 2,4-dinitrotoluene affects expression ISO RGD:1309247 6480464 2, 4-dinitrotoluene affects the expression of TJP3 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression ISO RGD:1309247 6480464 2, 6-dinitrotoluene affects the expression of TJP3 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:1319483 6480464 Lactic Acid results in decreased expression of TJP3 mRNA CTD PMID:30851411 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of TJP3 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:1319483 6480464 Decitabine affects the expression of TJP3 mRNA CTD PMID:23300844 5-fluorouracil affects expression ISO RGD:1319483 6480464 Fluorouracil affects the expression of TJP3 mRNA CTD PMID:16584549 6-propyl-2-thiouracil decreases expression ISO RGD:1309247 6480464 Propylthiouracil results in decreased expression of TJP3 mRNA CTD PMID:24780913 aflatoxin B1 decreases expression ISO RGD:1319483 6480464 Aflatoxin B1 results in decreased expression of TJP3 mRNA CTD PMID:21641981 aflatoxin B1 increases methylation ISO RGD:1319483 6480464 Aflatoxin B1 results in increased methylation of TJP3 exon CTD PMID:30157460 aflatoxin B2 decreases methylation ISO RGD:1319483 6480464 aflatoxin B2 results in decreased methylation of TJP3 intron CTD PMID:30157460 amiodarone decreases expression ISO RGD:1309247 6480464 Amiodarone results in decreased expression of TJP3 mRNA CTD PMID:17991464 arsane affects methylation ISO RGD:1319483 6480464 Arsenic affects the methylation of TJP3 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1319483 6480464 Arsenic affects the methylation of TJP3 gene CTD PMID:25304211 benzo[a]pyrene multiple interactions EXP 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to TJP3 promoter] CTD PMID:19654925 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of TJP3 mRNA CTD PMID:27195522 benzo[a]pyrene decreases expression ISO RGD:1319483 6480464 Benzo(a)pyrene results in decreased expression of TJP3 mRNA CTD PMID:21871943 benzo[b]fluoranthene decreases expression EXP 6480464 benzo(b)fluoranthene results in decreased expression of TJP3 mRNA CTD PMID:26377693 bisphenol A affects expression ISO RGD:1309247 6480464 bisphenol A affects the expression of TJP3 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1309247 6480464 bisphenol A results in decreased expression of TJP3 mRNA CTD PMID:29097150 cadmium dichloride increases methylation ISO RGD:1309247 6480464 Cadmium Chloride results in increased methylation of TJP3 promoter CTD PMID:22457795 calcitriol multiple interactions ISO RGD:1319483 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of TJP3 mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:1319483 6480464 Calcitriol results in increased expression of TJP3 mRNA CTD PMID:21592394 , PMID:26485663 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon analog results in decreased expression of TJP3 mRNA, Nanotubes, Carbon results in decreased expression of TJP3 mRNA CTD PMID:25620056 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of TJP3 mRNA CTD PMID:25554681 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of TJP3 mRNA CTD PMID:23125180 ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of TJP3 mRNA CTD PMID:18353800 cisplatin affects expression ISO RGD:1319483 6480464 Cisplatin affects the expression of TJP3 mRNA CTD PMID:23300844 cisplatin multiple interactions ISO RGD:1319483 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of TJP3 mRNA CTD PMID:27392435 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of TJP3 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:1319483 6480464 Cyclosporine results in decreased expression of TJP3 mRNA CTD PMID:24907557 diuron decreases expression ISO RGD:1309247 6480464 Diuron results in decreased expression of TJP3 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1319483 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 entinostat increases expression ISO RGD:1319483 6480464 entinostat results in increased expression of TJP3 mRNA CTD PMID:26272509 , PMID:27188386 entinostat multiple interactions ISO RGD:1319483 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TJP3 mRNA CTD PMID:27188386 hypochlorous acid decreases expression EXP 6480464 Hypochlorous Acid results in decreased expression of TJP3 mRNA CTD PMID:19376150 isotretinoin increases expression ISO RGD:1319483 6480464 Isotretinoin results in increased expression of TJP3 mRNA CTD PMID:18769122 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of TJP3 mRNA CTD PMID:20542052 methotrexate affects expression EXP 6480464 Methotrexate affects the expression of TJP3 mRNA CTD PMID:18502557 methotrexate increases expression ISO RGD:1319483 6480464 Methotrexate results in increased expression of TJP3 mRNA CTD PMID:21678067 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of TJP3 mRNA CTD PMID:19465457 N-methyl-4-phenylpyridinium increases expression ISO RGD:1309247 6480464 1-Methyl-4-phenylpyridinium results in increased expression of TJP3 mRNA CTD PMID:28801915 nickel atom decreases expression ISO RGD:1319483 6480464 Nickel results in decreased expression of TJP3 mRNA CTD PMID:25583101 paclitaxel decreases response to substance ISO RGD:1319483 6480464 TJP3 protein results in decreased susceptibility to Paclitaxel CTD PMID:16734730 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of TJP3 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1319483 6480464 Acetaminophen results in decreased expression of TJP3 mRNA CTD PMID:22230336 , PMID:29067470 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of TJP3 mRNA CTD PMID:19270015 phenylmercury acetate decreases expression ISO RGD:1319483 6480464 Phenylmercuric Acetate results in decreased expression of TJP3 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1319483 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TJP3 mRNA CTD PMID:27188386 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of TJP3 mRNA CTD PMID:17426115 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of TJP3 mRNA CTD PMID:28903501 progesterone multiple interactions EXP 6480464 NCOA2 protein affects the reaction [Progesterone results in decreased expression of TJP3 mRNA] CTD PMID:17556502 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of TJP3 mRNA CTD PMID:17556502 rac-lactic acid decreases expression ISO RGD:1319483 6480464 Lactic Acid results in decreased expression of TJP3 mRNA CTD PMID:30851411 resveratrol increases expression ISO RGD:1319483 6480464 resveratrol results in increased expression of TJP3 mRNA CTD PMID:25888808 SB 431542 increases expression ISO RGD:1319483 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of TJP3 protein CTD PMID:25670856 SB 431542 multiple interactions ISO RGD:1319483 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1319483 6480464 Silicon Dioxide analog results in decreased expression of TJP3 mRNA CTD PMID:25895662 sodium arsenite increases expression ISO RGD:1319483 6480464 sodium arsenite results in increased expression of TJP3 mRNA CTD PMID:29301061 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of TJP3 mRNA CTD PMID:20937368 testosterone multiple interactions ISO RGD:1319483 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of TJP3 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1319483 6480464 Testosterone results in increased expression of TJP3 mRNA CTD PMID:21592394 titanium dioxide affects expression EXP 6480464 titanium dioxide affects the expression of TJP3 mRNA CTD PMID:23557971 trichostatin A decreases expression ISO RGD:1319483 6480464 trichostatin A results in decreased expression of TJP3 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1319483 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TJP3 mRNA CTD PMID:27188386 urethane decreases expression ISO RGD:1319483 6480464 Urethane results in decreased expression of TJP3 mRNA CTD PMID:28818685 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of TJP3 mRNA CTD PMID:17963808 valproic acid increases expression ISO RGD:1319483 6480464 Valproic Acid results in increased expression of TJP3 mRNA CTD PMID:23179753 , PMID:23527032
Biological Process regulation of G1/S transition of mitotic cell cycle IGI MGI:MGI:88313 2290270 (MGI:MGI:5317249, PMID:21411630) MGI MGI:MGI:5317249 , PMID:21411630 Cellular Component apical plasma membrane IDA 2290270 (MGI:MGI:3041908, PMID:14622136) MGI MGI:MGI:3041908 , PMID:14622136 bicellular tight junction ISO UniProtKB:O95049 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 bicellular tight junction IDA 2290270 (MGI:MGI:3041908 more ... MGI MGI:MGI:3041908 more ... cell junction IEA UniProtKB-KW:KW-0965 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 cell junction ISO UniProtKB:O95049 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 cell surface ISO UniProtKB:O62683 2290270 MGI GO_REF:0000008, MGI:MGI:2154458 membrane IEA UniProtKB-KW:KW-0472 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 nucleoplasm ISO UniProtKB:O95049 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 nucleus ISO UniProtKB:O95049 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 plasma membrane IEA UniProtKB-KW:KW-1003 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 plasma membrane ISO UniProtKB:O95049 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 Molecular Function protein binding IPI UniProtKB:P25322 2290270 (MGI:MGI:5317249, PMID:21411630) MGI MGI:MGI:5317249 , PMID:21411630 protein binding IPI UniProtKB:O35054 more ... 2290270 (MGI:MGI:1350677, PMID:10601346) UniProtKB MGI:MGI:1350677 , PMID:10601346
Gene-Chemical Interaction Annotations
